Posts Tagged ‘birth control’
Contraception During COVID-19: Pharmacy Best Practices
Pharmacists should not allow postponed or cancelled appointments to keep patients from accessing birth control. It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs…
Read MoreClinical Considerations for Contraception During COVID: Extended Duration of IUDs and Implants
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).…
Read MoreClinical Considerations for Contraception During COVID: Patient Self-Administration
During the COVID-19 pandemic and beyond, patients may desire a contactless method of contraception. The subcutaneous (SQ) formulation of depot medroxyprogesterone acetate (DMPA), Depo-SubQ Provera, is an important option to offer patients. This may be of particular interest among patients who currently come in to the pharmacy or go to a clinic for their intramuscular (IM) injection.
Read More2020 CDC Update for Contraceptive Use in Women at High Risk for HIV
The CDC published updated guidelines to the 2016 U.S. Medical Eligibility Criteria for Contraceptive Use regarding women at high risk for HIV infection in April 2020.
Read MoreContraception for Your Transgender Patients
Terminology Navigating through a discussion about gender and sexuality with the many terms used today can be confusing. Here is a brief introduction to terminology regarding the multifaceted gender spectrum.1…
Read MoreTwirla: A New Contraceptive Patch
Twirla is a new contraceptive patch that was approved by the FDA earlier this month on February 14, 2020.
Read MoreNew Report Released on State Efforts to Expand Access to Contraception in Pharmacies
Download free 17-page report describing the current landscape of direct access to contraception in pharmacies, state legislative approaches and experiences, as well as implementation.
Read MoreMeet Slynd: A Novel Progestin-Only Pill
What’s this new pill? Slynd® is the new progestin-only oral contraceptive approved by the FDA in May 2019. This novel progestin-only pill (POP) contains drospirenone 4 mg in each active…
Read MoreInteractions Between Emergency Contraception and Other Hormonal Contraceptives
The American Society for Emergency Contraception (ASEC) recently held their annual EC Jamboree in Washington, DC. Participants included health care providers, researchers, reproductive health advocates, and pharmaceutical stakeholders. One highlight…
Read More